HAVCR2 and cancer: Moreover, we found that KIF18A had a positive correlation with immune checkpoints, such as PD-1, PD-L1, CTLA4, TIGIT, LAG3, HAVCR2, and PDCD1LG2 in a great many cancers (Figure 5E).